Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/183741
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKhannous-Lleiffe, Olfat-
dc.contributor.authorWillis, Jesse R.-
dc.contributor.authorSaus, Ester-
dc.contributor.authorCabrera Aguilera, Ignacio-
dc.contributor.authorAlmendros López, Isaac-
dc.contributor.authorFarré Ventura, Ramon-
dc.contributor.authorGozal, David-
dc.contributor.authorFarré, Núria-
dc.contributor.authorGabaldón, Toni-
dc.date.accessioned2022-03-03T17:50:02Z-
dc.date.available2022-03-03T17:50:02Z-
dc.date.issued2021-03-19-
dc.identifier.issn2076-2607-
dc.identifier.urihttp://hdl.handle.net/2445/183741-
dc.description.abstractHeart failure (HF) is a common condition associated with a high rate of hospitalizations and adverse outcomes. HF is characterized by impairments of either the cardiac ventricular filling, ejection of blood capacity or both. Sleep fragmentation (SF) involves a series of short sleep interruptions that lead to fatigue and contribute to cognitive impairments and dementia. Both conditions are known to be associated with increased inflammation and dysbiosis of the gut microbiota. In the present study, mice were distributed into four groups, and subjected for four weeks to either HF, SF, both HF and SF, or left unperturbed as controls. We used 16S metabarcoding to assess fecal microbiome composition before and after the experiments. Evidence for distinct alterations in several bacterial groups and an overall decrease in alpha diversity emerged in HF and SF treatment groups. Combined HF and SF conditions, however, showed no synergism, and observed changes were not always additive, suggesting preliminarily that some of the individual effects of either HF or SF cancel each other out when applied concomitantly.-
dc.format.extent16 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherMDPI-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/microorganisms9030641-
dc.relation.ispartofMicroorganisms, 2021, vol. 9, num. 3, p. 641-657-
dc.relation.urihttps://doi.org/10.3390/microorganisms9030641-
dc.rightscc-by (c) Khannous-Lleiffe, Olfat et al., 2021-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.sourceArticles publicats en revistes (Biomedicina)-
dc.subject.classificationModels animals en la investigació-
dc.subject.classificationInsuficiència cardíaca-
dc.subject.classificationSon-
dc.subject.classificationMicrobiota intestinal-
dc.subject.otherAnimal models in research-
dc.subject.otherHeart failure-
dc.subject.otherSleep-
dc.subject.otherGastrointestinal microbiome-
dc.titleA Mouse Model Suggests That Heart Failure and Its Common Comorbidity Sleep Fragmentation Have No Synergistic Impacts on the Gut Microbiome-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec714969-
dc.date.updated2022-03-03T17:50:02Z-
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/724173/EU//RETVOLUTION-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Biomedicina)
Publicacions de projectes de recerca finançats per la UE

Files in This Item:
File Description SizeFormat 
714969.pdf1.37 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons